Mohr Davidow Ventures

Mohr Davidow Ventures (MDV) is one of Silicon Valley's longest-tenured early-stage venture capital firms, founded in 1983 by Larry Mohr and Bill Davidow — the latter a former senior vice president at Intel during the era when the 8086 architecture became the industry standard. Headquartered in San Mateo, California, MDV has built approximately USD 1.85 billion in cumulative assets under management across its fund history. The firm leads rounds and targets early-stage technology companies that redefine or create large new markets, partnering with entrepreneurs leveraging big data, applied analytics, and web and mobile cloud platforms in verticals from social commerce to finance, online marketing, consumer-driven healthcare, and clean-tech IT. Over four decades MDV has made roughly 404 investments and delivered a long list of IPOs and acquisitions. Notable portfolio companies include Brocade, Coupa (NASDAQ: COUP), Rambus, Shutterfly, Proofpoint, nLight, Rally Software, Rocket Fuel, Aryaka Networks, Verinata Health (acquired by Illumina), Ticketfly, HealthTap, Infusionsoft, and Genomatica. The managing team spans approximately eight people with six partners, including Managing Partner Jon Feiber and general partners Josh Green, Sue Siegel, Erik Straser, and Bill Ericson, each covering distinct sectors from cleantech to life sciences and hardware. MDV now primarily manages its legacy portfolio rather than actively deploying new capital, with its most recent disclosed investment being a round in HealthTap in August 2023. The firm's most recent portfolio exit was Analyte Health, acquired by Brightstar Capital Partners in August 2025. Over forty years the partnership has earned a reputation for backing category-defining companies and then staying engaged through the full arc from early revenue to exit.